An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?


Yılmaz S., Elaldı N., Ertin H.

Anadolu Kliniği Tıp Bilimleri Dergisi, cilt.25, sa.1, ss.79-84, 2020 (Hakemli Dergi)